Walgreens Stock Gets a Boost After Beating Earnings Estimates—But the Chain Still Needs a Prescription for Growth

Walgreens needs a strong prescription–for recovery. After Walgreens CEO Stefano Pessina called the second quarter “the most difficult” since the company’s acquisition of Alliance Boots in 2014, Walgreens Boots Alliance surprised Wall Street by beating third-quarter earnings, reporting adjusted earnings of $1.47 per share compared to Refinitiv expectations of $1.43. The drugstore chain’s stock shot […]

Pfizer Betting Big on Cancer Research in $11.4 Billion Acquisition of Array BioPharma

Pfizer is delving deeper into cancer research with a roughly $11.4 billion deal for Array BioPharma, a drug developer that has seen its shares soar since announcing positive clinical trial results earlier this spring. Pfizer said Monday it will pay $48 per share in cash for Array, whose product portfolio includes a treatment combination used […]

Eye on A.I.— Why Standards Are Critical to Improving Artificial Intelligence

Improving artificial intelligence to help prevent heart attacks doesn’t just depend on innovation. It also hinges on creating standards, the wonky underpinnings of the technology agreed to by companies and government agencies. For example, the Consumer Technology Association, which hosts the annual CES tech show in Las Vegas, recently created an A.I. working group made […]

Private Insurance Would Not Be Eradicated Under Medicare for All—But It Would Take a Huge Hit

Sen. Kamala Harris defended Sen. Bernie Sanders’ Medicare for All legislation Monday night at CNN’s town hall, correcting moderator Don Lemon’s statement that the new healthcare plan would “effectively eliminate private insurance.” Harris acknowledged that Medicare for All would phase out private insurance as “the main source, but there would still be supplemental” plans available. […]

Why Accenture Bought a Digital Ad Agency

This article first appeared in Data Sheet, Fortune’s daily newsletter on the top tech news. To get it delivered daily to your in-box, sign up here. Never has the notion of swimming outside one’s lane been so exciting. Accenture, the spawn of Arthur Andersen turned consultant turned marketing guru, is buying Droga5, a buzzy advertising […]

How Artificial Intelligence Could Humanize Healthcare

Using artificial intelligence in healthcare could actually make medicine more human by giving doctors more time to interact with their patients. The technology promises to improve healthcare by making it more effective and speedy by eliminating some of the mundane functions that eat up doctors’ time, Eric Topol, founder and director of the non-profit Scripps […]

AstraZeneca Will Pay Up to $6.9 Billion for Rights to Japanese Drugmaker’s Cancer Drug

AstraZeneca is aiming to expand its presence in the oncology industry with a new drug rights acquisition. The pharmaceutical company said on Thursday that it’s agreed to pay up to $6.9 billion for a cancer drug developed by Japanese drugmaker Daiichi-Sankyo. The sum includes an upfront payment of $1.4 billion and the possibility of paying […]

Xeralto to Become First Prescription Drug With TV Ads That Includes Pricing

Xeralto has been a popular drug-thinner for years–and the target of more than 25,000 lawsuits recently settled by Bayer AG and Johnson & Johnson for $775 million. Now Xeralto, a brand name for generic rivaroxaban, is getting some attention for something different. It’s about to become the first drug to include prices in television ads, […]

Measles Outbreak Prompts One New York County to Ban Unvaccinated Children From Public Spaces

A county in upstate New York has taken the unprecedented step to ban unvaccinated children from public places following a measles outbreak. Rockland County, which is about 40 miles north of New York City, said on Tuesday that children under 18 years of age who haven’t been vaccinated against the measles cannot attend any public […]